![Reid Waldman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Reid Waldman
Grundare på
VERADERMICS, INCORPORATED
Förmögenhet: 29 M $ per 2026-06-30
Profil
Reid Waldman is the founder of Veradermics, Inc., founded in 2019, holding the title of Chief Executive Officer & Director since 2022.
Dr. Waldman currently holds the position of Director at Achieve Life Sciences, Inc., starting in 2026.
Dr. Waldman completed undergraduate and doctorate degrees at the University of Missouri-Kansas City.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-02-05 | 234 872 ( 0,56 % ) | 29 M $ | 2026-06-30 | |
| 2026-05-29 | 0 ( -.--% ) | - $ | 2026-06-30 |
Aktiva positioner av Reid Waldman
| Företag | Position | Start |
|---|---|---|
| VERADERMICS, INCORPORATED | Grundare | 2019-01-01 |
| ACHIEVE LIFE SCIENCES, INC. | Direktör/Styrelseledamot | 2026-05-29 |
Reid Waldmans utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
20
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
University of Missouri-Kansas City
 University of Missouri-Kansas City Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
Veradermics, Inc.
 Veradermics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company for treatment of dermatology and aesthetics problems | Health Technology |
